Call Us: +44 (0) 1752 753723[email protected]

Trial of new stem cell therapy for dystrophic epidermolysis bullosa (RDEB) gives promising results

Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition, recessive dystrophic epidermolysis bullosa (RDEB), have been published. RDEB is a painful skin disease in which very minor skin injury leads to blisters and poorly healing wounds. About 1,000 people in...